Clinical Trials
5 trialsNCT05806814 2026-05-27
OU-SCC-EXCITE
University of Oklahoma
Phase 1 Active not recruiting
NCT07219147 2026-04-20
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer
City of Hope Medical Center
Phase 1 Recruiting
NCT03024216 2021-05-26
Clinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer
University of Hawaii
Phase 1 Completed
NCT02036918 2020-03-31
Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer
Duke University
Phase 1 Completed
NCT01832870 2017-08-24
Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer
Prostate Oncology Specialists, Inc.
Phase 1 Completed